Digital Multimodality Platform for Mental and Brain Health with Neuroplastogens
Our Mission is to enhance the safety, effectiveness and accessibility of mental and CNS health therapies, by combining innovative digital treatment methodologies and neuroplastogens, including available compounds such as Ketamine and Cannabis, as well as a pipeline of additional innovative drugs.
Our Vision is to lead a mental and brain health revolution through the synergy of neuroplastogens with AI, providing comprehensive care that is accessible globally.
Our initial offering is a multimodality approach for mental and brain health
Digital Platform
Supporting at home and in-clinic ketamine treatments. Initially for Depression, anxiety and PTSD, followed by CNS indications.
Integration of Music, visuals and AI
Personalized treatment, enhanced with proven techniques including AI-driven CBT (Cognitive behavioral therapy), music and video based set and setting and EMDR (simultaneously experiencing bilateral stimulation, typically eye movements) to maximize therapeutic outcomes through patented personalized entrainment and biofeedback approaches.
Accessible and Scalable
Supports providers of prescribed ketamine treatments, enhancing patient convenience and safety.
The Role of Music, Visuals and AI in Therapy
Music and Video as Catalysts
Customized soundscapes and visuals are to improve both the session and in between sessions experience, neuroplasticity and patient outcomes in conjunction with (initially) ketamine.
AI-Driven Personalization
Use of predictive analytics and generative AI to adapt the treatment regimen, and creating adaptive music and visual environments tailored to each patient’s emotional and physiological state. This is paired with highly scalable, computerized psychotherapy tools employing proven methods such as Cognitive Processing Therapy (CPT), Eye Movement Desensitization and Reprocessing (EMDR), VR with music and visuals, and tACS/tDCS. These tailored treatments aim to optimize both emotional and physiological healing.
Synergy in Treatment
The combination of neuroplastogens, music and visuals creates an optimal state for therapeutic breakthroughs, enabling perceptual, emotional, and even social entrainment. Our digital tools are also enhancing the in-between sessions treatment, creating a full fledged Ketamine Assisted Psychotherapy (KAP), that will be later extended to additional neuroplastogens.
Innovative Nose to Brain Technology
Advanced proprietary Nano-particle technology for significantly enhanced drug delivery to the brain, enabling higher potency at lower dosing. The initial improvement over existing Nasal Ketamine solutions is geared toward at-home treatment of major depressive disorder (MDD), PTSD, and anxiety.
The Nano-particle technology ensures high bioavailability and targeted effects, reducing side effects and enhancing efficacy. It is applicable to a range of other psychedelics to be used for a variety of mental health and CNS indications we are developing.